These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19959755)

  • 1. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.
    Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
    Diabetes; 2010 Mar; 59(3):686-93. PubMed ID: 19959755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
    Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
    Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.
    Novosyadlyy R; Lann DE; Vijayakumar A; Rowzee A; Lazzarino DA; Fierz Y; Carboni JM; Gottardis MM; Pennisi PA; Molinolo AA; Kurshan N; Mejia W; Santopietro S; Yakar S; Wood TL; LeRoith D
    Cancer Res; 2010 Jan; 70(2):741-51. PubMed ID: 20068149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.
    Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
    Endocr Relat Cancer; 2010 Dec; 17(4):941-51. PubMed ID: 20801951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.
    Ferguson RD; Gallagher EJ; Cohen D; Tobin-Hess A; Alikhani N; Novosyadlyy R; Haddad N; Yakar S; LeRoith D
    Endocr Relat Cancer; 2013 Jun; 20(3):391-401. PubMed ID: 23572162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.
    Gallagher EJ; Zelenko Z; Tobin-Hess A; Werner U; Tennagels N; LeRoith D
    Diabetologia; 2016 Sep; 59(9):2018-25. PubMed ID: 27241182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice.
    Kim H; Pennisi PA; Gavrilova O; Pack S; Jou W; Setser-Portas J; East-Palmer J; Tang Y; Manganiello VC; Leroith D
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1227-36. PubMed ID: 16682489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor.
    Gallagher EJ; Alikhani N; Tobin-Hess A; Blank J; Buffin NJ; Zelenko Z; Tennagels N; Werner U; LeRoith D
    Diabetes; 2013 Oct; 62(10):3553-60. PubMed ID: 23835331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice.
    Zelenko Z; Gallagher EJ; Antoniou IM; Sachdev D; Nayak A; Yee D; LeRoith D
    Endocr Relat Cancer; 2016 Sep; 23(9):747-58. PubMed ID: 27435064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.
    Mosa R; Huang L; Li H; Grist M; LeRoith D; Chen C
    Am J Physiol Regul Integr Comp Physiol; 2018 Jan; 314(1):R71-R83. PubMed ID: 28903914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer model.
    Rostoker R; Bitton-Worms K; Caspi A; Shen-Orr Z; LeRoith D
    Endocrinology; 2013 May; 154(5):1701-10. PubMed ID: 23515289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice.
    Ben-Shmuel S; Scheinman EJ; Rashed R; Orr ZS; Gallagher EJ; LeRoith D; Rostoker R
    J Endocrinol; 2015 Dec; 227(3):143-151. PubMed ID: 26383532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.
    Kim H; Haluzik M; Asghar Z; Yau D; Joseph JW; Fernandez AM; Reitman ML; Yakar S; Stannard B; Heron-Milhavet L; Wheeler MB; LeRoith D
    Diabetes; 2003 Jul; 52(7):1770-8. PubMed ID: 12829645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly specific role of the insulin receptor in breast cancer progression.
    Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
    Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
    Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
    Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden.
    Connelly L; Barham W; Onishko HM; Sherrill T; Chodosh LA; Blackwell TS; Yull FE
    Oncogene; 2011 Mar; 30(12):1402-12. PubMed ID: 21076466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.
    Zhao H; Yakar S; Gavrilova O; Sun H; Zhang Y; Kim H; Setser J; Jou W; LeRoith D
    Diabetes; 2004 Nov; 53(11):2901-9. PubMed ID: 15504971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The R-Enantiomer of Ketorolac Delays Mammary Tumor Development in Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) Mice.
    Peretti AS; Dominguez D; Grimes MM; Hathaway HJ; Prossnitz ER; Rivera MR; Wandinger-Ness A; Kusewitt DF; Hudson LG
    Am J Pathol; 2018 Feb; 188(2):515-524. PubMed ID: 29169987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.
    Dong S; Ruiz-Calderon B; Rathinam R; Eastlack S; Maziveyi M; Alahari SK
    Int J Cancer; 2020 May; 146(9):2576-2587. PubMed ID: 31525254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.